Hyun Kim, Radiation Oncologist at Wash University Radiation Oncology, shared a post on X about a recent paper by Bengt Glimelius et al., commenting:
“LARCT-US Swedish prospective cohort study published! 273 patients with high risk rectal cancer, rapido inclusion, but older and more advanced tumors treated with Short-course radiotherapy (SCRT) and 2 less chemotherapy cycles than rapido. 3-year LRR 6% no more events past 3-years. Real data.”
Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US) published in eClinical Medicine.
Authors: Bengt Glimelius, Tanweera Khan, Karin Adolfsson, Eva Angenete, Åke Berglund, Kristina Bonde, Nils Elander, Tone Fokstuen, Johan Haux, Israa Imam, Cecilia Lagerbäck, Ingrid Ljuslinder, Andrzej Piwowar, Marie Zajicova, Per J. Nilsson.
Additional information
Source: Hyun Kim/X